Drug Approval Package: Alteplase

Company:  Genentech
Application No.:  103172-Supplement 1055
Approval Date: 6/18/1996

Proper name: Alteplase
Tradename: Activase
Manufacturer: Genentech, Inc, South San Francisco, CA, License #1048
Indication for Use: Management of acute ischemic stroke in adults, for improving neurological recovery, and reducing the incidence of disability
Approval Date: 6/18/96
Type of submission: Product license supplement

Date updated: July 5, 2017

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English